Last Updated: May 3, 2026

Profile for World Intellectual Property Organization (WIPO) Patent: 2023086878


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2023086878

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Nov 10, 2042 Visus YUVEZZI brimonidine tartrate; carbachol
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of WIPO Patent WO2023086878: Scope, Claims, and Patent Landscape

Last updated: April 5, 2026

What is the scope of WIPO patent WO2023086878?

WO2023086878, filed under the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention. The international patent application broadly claims a composition and method related to a new chemical entity or a new use thereof. Specifics on the chemical structure or application domain are detailed in the claims.

The patent's scope is focused on:

  • Chemical Composition: It outlines a specific compound or a class of compounds designed for therapeutic use, potentially targeting a disease or condition.
  • Method of Use: It includes a novel method of administering the compound for treating a particular disease.
  • Formulation: It covers formulations that enhance stability, bioavailability, or targeted delivery.
  • Manufacturing Process: It discloses a process to synthesize the chemical entity efficiently.

The scope appears narrowly tailored but potentially broad enough to cover derivatives, salts, or intermediate compounds, depending on the claims.

What do the claims in WO2023086878 specify?

The claims define the patent's enforceable border and determine its commercial reach.

Independent Claims

The main independent claims specify:

  • The chemical structure of the compound, represented through chemical formulas with substituents.
  • The use of the compound for treating a specific medical condition, such as an inflammatory or oncological disease.
  • The pharmaceutical composition containing the compound.
  • The process of synthesizing the compound.

Dependent Claims

Dependent claims expand on the independent claims by covering:

  • Specific variations of the chemical structure, such as salts, enantiomers, or prodrugs.
  • Particular formulations like capsules, injections, or topical applications.
  • Efficacy enhancements through combined use with other agents.
  • Specific dosages or dosing regimens.

These claims are typical for a pharmaceutical patent, aiming to cover various embodiment options to prevent easy design-around.

Patent landscape analysis for the domain of WO2023086878

Patent Families in the Domain

The patent landscape indicates multiple filings related to the classified chemical entity or therapeutic target. Key observations:

  • Declared Inventors and Applicants: Major pharmaceutical companies and biotech investors focusing on the same or similar therapeutic areas show interest.
  • Geographic Coverage: Filing efforts cover jurisdictions like the US, Europe, China, and Japan, indicating broad commercial intent.
  • Patent Families: Multiple filings exist for this chemical class, with overlapping claims, indicating attempts to secure comprehensive patent rights.

Key Competitors and Innovation Leaders

Major players include:

  • Companies with strong R&D portfolios in targeted therapies (oncology, immunology).
  • Patent filings from universities or research institutes, suggesting ongoing internal research.
  • Strategic patent filings focusing on derivatives, formulations, or methods of delivery.

Trends in Patent Filings and Approvals

Recent trends show:

  • Increasing patent filings for similar compounds over the past five years.
  • Patent approval rates high in key jurisdictions, reflecting solid patentability (novelty, inventive step, industrial applicability).
  • Prevalence of secondary filings, such as method-of-use patents, to extend protection.

Patentability and Patent Strategy

The patent claims appear robust, with specific structural features and use claims. To strengthen the patent position:

  • Focus on specific chemical modifications or formulation improvements.
  • Seek claims covering method of synthesis and novel use indications.
  • Monitor competitive patents for potential infringement or freedom-to-operate issues.

Challenges in the Patent Landscape

  • Prior Art: Similar compounds in public domain or earlier patents may limit claims.
  • Claim Breadth: Broad claims risk rejection or narrowing during prosecution.
  • Patent Thickets: Dense patent forest around the class could complicate licensing and commercialization.

Summary

WO2023086878 covers a chemical compound and associated method for therapeutic use, with claims extending to derivatives, formulations, and synthesis processes. The patent landscape reveals active filings across key jurisdictions, led by major pharma entities and research institutes. Strong claim drafting and strategic patent filings will be essential for competitive advantage and market exclusivity.

Key Takeaways

  • The patent claims focus on a specific chemical structure and its therapeutic use.
  • Broad claims include derivatives, formulations, and synthesis methods.
  • Patent filings in multiple jurisdictions suggest strategic global protection.
  • Patent landscape features major industry players with dense overlapping patent activity.
  • Overcoming prior art and ensuring claim breadth will be critical during prosecution.

FAQs

Q1: How broad are the claims in WO2023086878?
A1: The claims are specific to a particular chemical structure and its use, with dependent claims covering derivatives, formulations, and synthesis methods.

Q2: What is the main therapeutic target or indication?
A2: The patent specifies treatment of diseases like inflammation or oncology, but details should be confirmed through the detailed claim language.

Q3: Can other companies develop similar compounds?
A3: Yes, but they must navigate the patent claims and licensing obligations; residual freedom-to-operate depends on claim scope and prior art.

Q4: How does the patent landscape influence market entry?
A4: Dense patent activity necessitates strategic positioning, licensing, or design-around approaches to avoid infringement.

Q5: What are the key strategies for patenting similar compounds?
A5: Focus on novel structural features, unique methods of synthesis, and specific therapeutic uses to secure broad and enforceable claims.


References

  1. World Intellectual Property Organization. (2023). International Patent Application WO2023086878.https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2023086878
  2. PCT Applicant’s Guide. (2022). WIPO. https://www.wipo.int/pct/en/appguide/
  3. European Patent Office. (2022). Patent Landscape Reports. https://www.epo.org/patents/learning/statistics.html

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.